Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vitrolife AB's book value per share for the quarter that ended in Jun. 2026 was kr60.04.
During the past 12 months, Vitrolife AB's average Book Value Per Share Growth Rate was -38.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -22.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 15.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 34.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Vitrolife AB was 101.90% per year. The lowest was -22.20% per year. And the median was 16.60% per year.
Vitrolife AB's current price is kr86.375. Its book value per share for the quarter that ended in Jun. 2026 was kr60.04. Hence, today's PB Ratio of Vitrolife AB is 1.44.
During the past 13 years, the highest P/B Ratio of Vitrolife AB was 26.30. The lowest was 0.99. And the median was 9.18.
Good Sign:
Vitrolife AB stock PB Ratio (=1.42) is close to 2-year low of 1.32.
Vitrolife AB (CHIX:VITRs) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Vitrolife AB Book Value per Share Related Terms
Vitrolife AB Book Value per Share Historical Data
* Premium members only.
The historical data trend for Vitrolife AB's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:VITRS vs ABT, SYK, MDT: Book Value per Share Comparison
For the Medical Devices subindustry, Vitrolife AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitrolife AB PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Vitrolife AB's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vitrolife AB (CHIX:VITRS) has a Book Value per Share of kr60.04 as of Jun. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Vitrolife AB and its competitors.
Is Vitrolife AB's Book Value per Share too high?
Vitrolife AB's current Book Value per Share is kr60.04. Overall, Vitrolife AB has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Vitrolife AB's Book Value per Share compare to ABT and SYK?
Vitrolife AB's Book Value per Share of kr60.04 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Medical Devices & Instruments company?
A good Book Value per Share depends on the Medical Devices & Instruments industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Vitrolife AB and its competitors. Vitrolife AB's current Book Value per Share is kr60.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitrolife AB stock overvalued right now?
Vitrolife AB (CHIX:VITRS) has a current Book Value per Share of kr60.04. The stock's GF Value™ is kr185.92, compared to a current price of kr86.38 — trading 53.5% below its estimated fair value. The current Book Value per Share is kr60.04. Vitrolife AB's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Vitrolife AB (CHIX:VITRS), the current Book Value per Share is kr60.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vitrolife AB (CHIX:VITRS) Overvalued in 2026?
Based on GuruFocus' analysis, Vitrolife AB stock appears to be undervalued.
The current stock price of kr86.38 is trading 53.5% below its estimated GF Value™ of kr185.92.
Key valuation signals for CHIX:VITRS:
Book Value per Share: kr60.04
GF Value™: kr185.92 vs. price of kr86.38 (53.5% below fair value)
No single metric tells the full story. See the CHIX:VITRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
77GF Score
Get the complete analysis for CHIX:VITRS
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:VITRS has been successfully added to your 
